Ozempic and its chemical cousins made their name as weight-loss drugs. Increasingly, that may be the least interesting thing about them. A massive VA-linked study analyzing over 100 million U.S. patient records found GLP-1 drugs associated with reduced risk across 42 separate health conditions — including substance abuse disorders, suicidal ideation, schizophrenia, neurocognitive disorders like Alzheimer's, liver cancer, and life-threatening blood clots. The heart evidence is